ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF
Provided herein are activatable antibodies that specifically bind to CD166 and conjugated activatable antibodies that specifically bind to CD166. Also provided are methods of making and using these activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
08.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are activatable antibodies that specifically bind to CD166 and conjugated activatable antibodies that specifically bind to CD166. Also provided are methods of making and using these activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications. |
---|---|
Bibliography: | Application Number: US202016934955 |